EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential Diagnostic and Therapeutic Tactics for Pleurisy of Various Etiologies (Review)

Oleksandr Nevzghoda

SSP Modern Pharmacy and Medicine · 27.04.2026 · 6 (2) · 19

DOI: 10.53933/0wq85c91 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SSP Modern Pharmacy and Medicine, online erschienen am 27.04.2026. Verfasst von Oleksandr Nevzghoda. Die Arbeit nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pleurisy of various etiologies remains an urgent clinical problem of modern pulmonology and thoracic surgery due to the high incidence of pleural effusions, pleural empyema, a significant duration of hospitalization and the risk of severe complications. The complexity of the clinical picture, the variety of etiological factors and the need for timely differential diagnosis determine the need to systematize modern approaches to the diagnosis and treatment of these conditions. The purpose of the work was to review modern scientific sources on epidemiology, etiology, pathophysiology, diagnosis, and treatment of pleurisy of various etiologies. A review and content analysis of scientific publications of international and national sources devoted to the problem of pleurisy, pleural effusions and pleural empyema have been carried out. Clinical recommendations of professional medical societies, results of clinical, cohort and retrospective studies, systematic reviews, as well as publications related to pharmacotherapy, surgical treatment and pharmacoeconomic aspects of patient management are analyzed. An analysis of the literature showed that the most common causes of pleural effusions are bacterial pneumonia, malignant neoplasms, tuberculous pleurisy, heart failure and pulmonary embolism. The etiological structure of pleural infections is represented mainly by Staphylococcus aureus, streptococci, gram-negative bacteria, and anaerobic flora. The paper summarizes modern approaches to the diagnosis of pleural effusions, including clinical assessment, general clinical laboratory methods of examination, immunological examination methods, radiography, ultrasound diagnostics, computed tomography, thoraco- and video thoracoscopy, trastoracal puncture under the control of computed tomography, fibrobronchoscopy for limited exudative pleurisy, laboratory analysis of pleural fluid, laboratory analysis of sputum. The role of the latest biomarkers, in particular soluble urokinase plasminogen activator receptor and procalcitonin, in predicting the course of pleural infection and the choice of treatment tactics is considered. Modern recommendations for the treatment of pleural empyema are presented, which include antibiotic therapy, pleural drainage, intrapleural fibrinolytic therapy, as well as surgical methods, including video-assisted thoracoscopic surgery and decortication. Clinical cases, results of cohort studies and the prognostic value of the RAPID scale were analyzed. Special attention is paid to the pharmacoeconomic aspects of treatment, the use of ABC/VED analysis to optimize pharmacotherapy, as well as innovative approaches to the treatment of pleurisy, in particular halotherapy and extracorporeal blood hyperthermia. Data on the association of pleural infections with comorbid conditions such as liver disease, pancreatitis, and other systemic pathologies have also been summarized. The latest methods of halotherapy in the treatment of fibrinous and exudative pleurisy are considered. The latest methods with the use of intravenous administration of alcohol solutions in the treatment of covid pneumonia with pleuropneumofibrosis are presented. It has been proven that acute vasculitis is of leading importance in the development of covid pneumonia. Standards for the treatment of fibrinous and exudative pleurisy have been developed. Therefore, modern tactics of management of patients with pleurisy of various etiologies are based on early diagnosis, the complex use of instrumental imaging methods, and rational antibiotic therapy in combination with adequate drainage of the pleural cavity. Minimally invasive surgical methods, the use of modern biomarkers and immune markers, immunological diagnostic methods, and a personalized approach to therapy play an important role in improving treatment outcomes. Promising areas for further research are the introduction of innovative treatment methods, improvement of pharmacoeconomic models for optimizing pharmacotherapy and integration of a multidisciplinary approach to the management of patients with pleural infections.

Zitieren

APA

Nevzghoda, O. (2026). Differential Diagnostic and Therapeutic Tactics for Pleurisy of Various Etiologies (Review). SSP Modern Pharmacy and Medicine, 6(2), 19. https://doi.org/10.53933/0wq85c91

Vancouver

Nevzghoda O. Differential Diagnostic and Therapeutic Tactics for Pleurisy of Various Etiologies (Review). SSP Modern Pharmacy and Medicine. 2026;6(2):19. doi:10.53933/0wq85c91

BibTeX
@article{Nevzghoda2026,
  author = {Nevzghoda, Oleksandr},
  title = {Differential Diagnostic and Therapeutic Tactics for Pleurisy of Various Etiologies (Review)},
  journal = {SSP Modern Pharmacy and Medicine},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {19},
  doi = {10.53933/0wq85c91}
}
Kostenlos starten →